Bharat Biotech's partner Ocugen seeks approval for Covaxin in Canada

The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 adults, it said on Thursday.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3rlKtwU
via IFTTT